Anti-tumor necrosis factor-α therapy and paradoxical autoimmunity in inflammatory bowel disease: a need for risk-aware monitoring
Intestinal Research · 30.07.2026 · 24 (3) · 387-388
DOI: 10.5217/ir.2026.00169 ↗Kurz gefasst
Editorial in der Zeitschrift Intestinal Research, erschienen am 30.07.2026. Verfasst von Ji Eun Kim. Beteiligte Einrichtung: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. happyjinny0706@gmail.com. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. happyjinny0706@gmail.com.
Zitieren
APA
Kim, J. E. (2026). Anti-tumor necrosis factor-α therapy and paradoxical autoimmunity in inflammatory bowel disease: a need for risk-aware monitoring. Intestinal Research, 24(3), 387-388. https://doi.org/10.5217/ir.2026.00169
Vancouver
Kim JE. Anti-tumor necrosis factor-α therapy and paradoxical autoimmunity in inflammatory bowel disease: a need for risk-aware monitoring. Intestinal Research. 2026;24(3):387-388. doi:10.5217/ir.2026.00169
BibTeX
@article{Kim2026,
author = {Kim, Ji Eun},
title = {Anti-tumor necrosis factor-α therapy and paradoxical autoimmunity in inflammatory bowel disease: a need for risk-aware monitoring},
journal = {Intestinal Research},
year = {2026},
volume = {24},
number = {3},
pages = {387--388},
doi = {10.5217/ir.2026.00169}
}
EUVIMED